Rigel Pharmaceuticals, Inc. (RIGL)
45.69
+1.17
(+2.63%)
USD |
NASDAQ |
Nov 12, 16:00
45.77
+0.08
(+0.18%)
After-Hours: 20:00
Rigel Pharmaceuticals Free Cash Flow (Quarterly) : 34.35M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 34.35M |
| June 30, 2026 | -39.69M |
| March 31, 2026 | 2.725M |
| December 31, 2025 | 21.99M |
| September 30, 2025 | 24.02M |
| June 30, 2025 | 30.54M |
| March 31, 2025 | -0.893M |
| December 31, 2024 | 14.48M |
| September 30, 2024 | 21.67M |
| June 30, 2024 | 0.08M |
| March 31, 2024 | -5.151M |
| December 31, 2023 | -6.24M |
| September 30, 2023 | -1.359M |
| June 30, 2023 | 5.93M |
| March 31, 2023 | -19.07M |
| December 31, 2022 | -21.98M |
| September 30, 2022 | -13.49M |
| June 30, 2022 | -12.88M |
| March 31, 2022 | -25.86M |
| December 31, 2021 | -19.06M |
| September 30, 2021 | -10.47M |
| June 30, 2021 | 54.81M |
| March 31, 2021 | -20.03M |
| December 31, 2020 | -16.08M |
| September 30, 2020 | -19.68M |
| Date | Value |
|---|---|
| June 30, 2020 | -13.99M |
| March 31, 2020 | -3.70M |
| December 31, 2019 | -10.26M |
| September 30, 2019 | -14.99M |
| June 30, 2019 | -16.77M |
| March 31, 2019 | -0.946M |
| December 31, 2018 | 11.58M |
| September 30, 2018 | -20.24M |
| June 30, 2018 | -27.68M |
| March 31, 2018 | -23.59M |
| December 31, 2017 | -19.77M |
| September 30, 2017 | -17.67M |
| June 30, 2017 | -19.48M |
| March 31, 2017 | -20.80M |
| December 31, 2016 | -12.47M |
| September 30, 2016 | -22.82M |
| June 30, 2016 | -18.66M |
| March 31, 2016 | -22.74M |
| December 31, 2015 | -13.93M |
| September 30, 2015 | -9.764M |
| June 30, 2015 | -18.22M |
| March 31, 2015 | 17.96M |
| December 31, 2014 | -15.20M |
| September 30, 2014 | -18.34M |
| June 30, 2014 | -20.02M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Cytokinetics, Inc. | -124.72M |
| Inovio Pharmaceuticals, Inc. | -15.27M |
| United Therapeutics Corp. | 125.80M |
| Verastem, Inc. | -41.09M |
| Marker Therapeutics, Inc. | -3.716M |